Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 11:19 am Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | Capital International Investors | 20,318,820 6% | 20,318,820 (New Position) | View |
| 2022-02-09 12:17 pm Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | LAV Biosciences Fund V L.P. | 25,406,680 7.8% | 25,406,680 (New Position) | View |
| 2022-02-04 09:06 am Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | WELLINGTON MANAGEMENT GROUP LLP | 21,460,705 6.36% | 21,460,705 (New Position) | View |
| 2021-01-21 4:46 pm Purchase | 13D | GRACELL BIOTECHNOLOGIES INC SP GRCL | ORBIMED ADVISORS LLC | 29,853,364 9.1% | 29,853,364 (New Position) | View |
| 2021-01-15 08:00 am Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | Temasek Holdings (Private) Ltd | 49,509,702 15.1% | 49,509,702 (New Position) | View |